JANE WEINBERG: Open Payments
NPI 1861575755 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,015 in 78 payments from 14 companies in 2025. Trend: 2023 $6,751 · 2024 $2,836 · 2025 $4,015
Food & beverage: $4,003Education: $12
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $608 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $513 |
| Alkermes, Inc. | 8 | $504 |
| Vanda Pharmaceuticals Inc. | 22 | $500 |
| Axsome Therapeutics, Inc. | 5 | $411 |
| Braeburn Inc. | 4 | $304 |
| E.R. Squibb & Sons, L.L.C. | 6 | $275 |
| Teva Pharmaceuticals USA, Inc. | 2 | $234 |
| Tris Pharma Inc | 11 | $229 |
| ABBVIE INC. | 2 | $149 |
Products named: CAPLYTA, INVEGA SUSTENNA, Auvelity, FANAPT, LYBALVI, BRIXADI, COBENFY, Dyanavel XR.
Industry payments across TN — which companies pay providers there.
